generics

GSK Fined for Blocking Copies of Seroxat

Topics • Chemistry

DCAT Week ’16

NICE Approves Two Biosimilars for Arthritis

Global Data Sees Indian Generics Soaring

Roche Wins Patent Dispute Against Cipla

Teva and Takeda in Japanese Generics JV

Imprimis Touts Cheaper Daraprim Alternative

Topics • Technology

Chances and Hurdles for Biosimilars

FDA Approves Mylan’s Yasmin Copies

Mylan Makes New Bid for Perrigo

Topics • Strategy

Significant Value Creation

Perrigo Acquires Scar Management Brand

Lilly Wins Court Ruling on Alimta Patent

Boehringer Selling US Generics Arm to Hikima

Teva to Acquire the Generics Activities of Allergan for Over $40 Billion

Novartis Can Sell Neupogen Copy in US in September

Teva and Mylan Slug it out Over Takeover Bid

Perrigo Buying GSK, Novartis Consumer Brands

Teva to Refund Buyers for Cephalon Drug Overpay

Actavis Ordered to Keep Selling Alzheimer Drug

Dr Reddy’s Pleased With Fiscal 2015 Performance

Topics • Strategy

Current and Future Trends for Pharmaceutical Logistics

Mylan Sweetens its Bid for Perrigo

Mylan Board Unanimously Rejects Teva’s Bid

Mylan Said to Prepare Poison Pill Potion Against Teva

Daiichi Sankyo Unloads Entire Stake in Sun Pharma

Topics • Technology

Quality and Efficiency in Pharma Manufacturing

Endo International Tries to Spoil Valeant’s Salix Deal

CPhI Worldwide Announces International Advisory Board

Bayer Fails to Block Cancer Generic in India

Merck & Co Still Plans to buy Cubist, Despite Patent Setback

Mylan Trims Forecast Due to FDA Approval Delays

Teva to Name New Chairman?

Mylan to Pay Abbott $5.3 Billion for Non-US Business

Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

162 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Predictive Simulation in Pharma Production

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Thomson Reuters

F. Hoffmann-La Roche Ltd

Fitch Ratings

Saltigo GmbH

Deutsche Post DHL

Enigma Marketing Research

ARC Advisory Group GmbH & Co KG

Arthur D. Little

Camelot Management Consultants AG

SchüllerConsulting

Camelot Management Consultants AG

CMS Advisors GmbH & Co. KG

Porsche Consulting